Moderna execs aren't the only ones to cash out big on the over hyped vaccine press releases that send their company stocks climbing. The Pfizer CEO Albert Bourla has dumped a whopping 62% of his stock totaling $5.6 million.
A recent announcement about the alleged glowing success of the Pfizer vaccine sent the stock up 16%.
The headline is "90% effectiveness in preliminary results". WOW!
A vaccine which will just reduce mild symptoms and have nothing to do with proving it reduces hospital duration or even death. That's how the studies were designed.
Designed to pass by making a "vaccine" which is only reducing mild symptoms. That's super important to force onto everyone, right? Sniffles? Sore throat? Cough? Well you MUST get this "life saving" vaccine... that isn't tested to save lives or reduce severe symptoms or reduce hospital stay... just minor symptoms... real important.
Not that any of this matters to the people who are just looking to make money off a semi-mandated or fully mandated vaccines. Because it still spells $$$ in sales of pretty useless "vaccines".
Boula's stock sales are the same as Moderna execs selling stocks when the price happened to go up. Under SEC Rule 10b5-1, execs can do "insider trading" by setting up predetermined sales of shares. So it's all "legal". He just saw the stock eventually going up and set that future selling position.
But it makes you wonder who decides when to do press releases? Cloud the CEO make positive press releases come up just before he has a sell order execute, thereby increasing the likelihood of the stock going up on the positive news before the selling happens? I think so. The same thing happened with MOderna. Coincidence? Hmmm.